Coccidioidomycosis is a mycotic disease caused by the dimorphic fungus Coccidioides immitis. Humans acquire the infection by inhalation of mycelial-phase arthroconidia which convert in host tissue to endosporulating spherules. The disease presents a diverse clinical spectrum that includes inapparent infection, primary respiratory disease usually with uncomplicated resolution, chronic pulmonary disease either stabilized or progressive, and extrapulmonary dissemination either acute, chronic, or progressive. The degree of severity varies considerably within each category.
Accumulated evidence in humans (6, 9, 10, 29, 39) and in experimentally infected animals (2, 3) suggests that cell-mediated immunity is critical for host defense in coccidioidomycosis. Typically, persons with primary, asymptomatic disease manifest strong cell-mediated immune responses to C. immitis antigens. Conversely, patients with chronic or progressive coccidioidomycosis have depressed cellular immune functions. The anergy is, in most patients, specific for C. immitis in that T-cell responses to non-coccidioidal antigens remain intact (6, 10) . In contrast to a Tlymphocyte hyporeactivity, patients with this disease characteristically show a B-cell hyperreactivity with increased serum levels of immunoglobulin G (IgG), IgA, and IgE antibodies (7, 31, 32, 36) .
Hyperproduction of IgE in atopic disorders such as allergic asthma, hay fever, and atopic dermatitis is well documented (18, 19, 22) . In addition, markedly elevated serum IgE has been reported in bronchopulmonary aspergillosis (11, 33) , chronic dermatophyte infections (21) , candidiasis (24, 27) , histoplasmosis (8) , leprosy (35) , parasitic infections (12, 15, 20, 34) , WiskottAldrich syndrome (42), DiGeorge's syndrome (23) , and Hodgkin's disease (41) . Each of these diseases is associated with a cellular immune defect(s), although the defect(s) varies in severity. This, coupled with the finding that IgE antibody production is regulated by T lymphocytes (17, 25, 28, 30, 43) , suggests that proliferative IgE responses are attributed to a defective T-suppressor cell population(s). Relevant to this is the finding that there are two types of T suppressor cells that regulate IgE synthesis (17, 28, 43) . One type regulates antigen-specific IgE responses (18) . The other type is antigen nonspecific and regulates IgE synthesis in general (28, 43 In a previous study of IgE in coccidioidomycosis (7), we reported that IgE serum levels were elevated in 13 (59%) of 22 patients with active disease. Serum IgE levels correlated with antiCoccidioides IgE which, in turn, correlated with immediate wheal and flare responses to coccidioidin (CDN). The present study was undertaken to further evaluate hyperproduction of IgE in this disease. Two significant new findings were revealed. First, IgE antibody production correlated with disease severity; i.e., serum IgE levels were significantly increased in patients with Coccidioides involvement of multiple organ systems when compared with patients having disease of a single organ system. Second, IgE antibody production to C. immitis was accompanied by IgE antibody production to non-coccidioidal allergens, a finding that suggests a dysfunction in antigen-nonspecific regulatory T lymphocytes.
MATERIALS AND METHODS
Study groups. The 97 patients comprising this study were divided into 26 patients with active pulmonary coccidioidomycosis, 59 patients with active disseminated disease, and 12 patients who had been in clinical remission (culture negative) for at least 1 year before the study (Table 1) . Of the patients with pulmonary disease, 4 had an acute, primary infection; the remaining 22 patients had chronic pulmonary coccidioidomycosis. Of the 59 patients with disseminated disease, 46 had disease of one organ system, i.e., skin and/or soft tissue, bone and/or joint, central nervous system, lymph nodes, genitourinary system, or eye; 13 had extrapulmonary disease of two or more organ systems. Coccidioidal involvement of an organ system was defined as a symptomatic lesion and a culture or biopsy positive for C. immitis. The exceptions to this were meningitis and endophthalmitis. The former was defined as neurological symptoms and an abnormal cerebrospinal fluid with anti-Coccidioides complement-fixing antibody. Endophthalmitis was defined as changing lesions consistent with granulomatous disease upon direct and indirect funduscopic examination after dilation of the pupil plus complement-fixing antibody in serum and documented evidence of coccidioidal infection elsewhere. To rule out coccidioidal organ system involvement, a complete history was taken and a physical examination, including funduscopy and chest roentgenograms, was performed in all patients. In addition, most patients had lumbar punctures, bone scans, and urine cultures (with prostatic massage in male patients) performed although the patients were asymptomatic with respect to these systems.
Of the 91 healthy subjects included, 23 were skin test positive (-5-mm induration at 24 or 48 h) to CDN (1:100; Cutter Laboratories, Berkeley, Calif.) or spherulin (usual test strength; Berkeley Biologicals, Berkeley, Calif.), and 68 were skin test negative.
Aseptically drawn blood specimens were allowed to clot at room temperature. Sera were separated by centrifugation and stored at -70°C until assayed.
IgE antibody assays. Total serum IgE levels were quantitated with the paper radioimmunosorbent test (Phadebas PRIST) purchased from Pharmacia Fine Chemicals, Inc., Piscataway, N.J. Reference IgE was included in each assay.
Specific IgE levels to common allergens were measured with the radioallergensorbent test (Phadebas RAST). Briefly, this assay consists of incubating serum with allergen-coated paper disks. Radiolabeled rabbit anti-human IgE is then added, and after incubation and washing, the amount of bound radioactivity is determined. Allergens included Bermuda grass, common ragweed, Dermatophagoides farinae (dust mite), dog epithelia, egg white, milk, mountain cedar, white oak, wormwood sagebrush, Alternaria tenuis, Aspergillus sp., and Cladosporium sp.
C. immitis-specific IgE levels were determined with the RAST test described above except that the paper disks were coated with C. immitis antigens. The three antigens were: CDN, prepared as a toluene-induced mycelial-phase lysate, provided by M. Huppert, Veterans Administration Hospital, San Antonio, Tex.; spherulin, an aqueous extract of spherules of C. immitis, obtained from Berkeley Biologicals; and the alkalisoluble, water-soluble cell wall extract of mycelia of C. immitis (9) . The antigens (350 ,ug) were coupled to the paper disks by cyanogen bromide activation (1) .
Statistical analyses. Differences in the frequency of elevated serum IgE levels among study groups were analyzed by chi-square analyses (14) . Correlation analyses were performed with Spearman's rank-sum correlation (14) .
RESULTS
Total serum IgE levels. A total of 7 (27%) of 26 patients with active pulmonary coccidioidomycosis and 23 (39%) of 59 patients with disseminated disease had elevated serum IgE levels (.185 U/ml) as compared with 2 (17%) of 12 patients in clinical remission and 2 (9%) of 23 healthy, CDN skin test-positive persons (Fig. 1 (Fig. 2) . As with total serum IgE levels, anti-Coccidioides IgE levels correlated with disease severity in terms of organ system involvement; i.e., 7 (54%) of 13 patients with Coccidioides involvement of two or more organ systems had IgE antibody to CDN as compared with 17 (24%) of 72 patients with involvement of a single organ system (pulmonary or extrapulmonary) (P < 0.05).
The correlation between total serum IgE levels and C. immitis-specific IgE levels was statistically significant ( Fig. 3; immitis mycelia (r = 0.76; P < 0.001).
The specificity of the IgE responses to CDN was assessed in RAST assays of 25 atopic persons not infected with C. immitis. Only two (8%) reacted to CDN-coated disks. This frequency of reactivity is significantly lower (P < 0.005) than that obtained in C. immitis-infected persons and establishes the specificity of CDN in RAST assays. Non-coccidioidal IgE. Among the panel of allergens, the highest frequency of reactivity was obtained with Bermuda grass extract, with 15 (47%) of 32 patients having demonstrable levels of anti-Bermuda grass IgE. The correlation between total serum IgE levels and Bermuda grass IgE levels (Fig. 5) was only slightly less (r = 0.51; P < 0.01) than that obtained with CDN IgE levels ( Fig. 3 ; r = 0.68; P < 0.001). Moreover, there existed a significant correlation between anti-CDN IgE levels and Bermuda grass IgE levels (r = 0.43; P < 0.05). Results obtained with this allergen and with the remaining 11 non-coccidioidal allergens provide conclusive evidence that IgE antibodies in coccidioidomycosis are directed against both coccidioidal and non-coccidioidal antigens. These responses were not attributed to the presence of atopic disorders commonly associated with elevated serum IgE, i.e., asthma, atopic dermatitis, and hay fever.
DISCUSSION
The results of the present study extend our earlier findings (7) 21 (66%) had demonstrable anti-C. immitis IgE. All but six of these had IgE antibodies to 1 or more of 12 allergens. Our finding that excessive production of IgE occurs with both coccidioidal and non-coccidioidal antigens is the first occurrence in our studies in which the immunological abnormality is not specific for C. immitis, at least in the majority of patients. These results suggest that a defect exists in the lymphocyte population which functions to regulate antigen-specific IgE and in the population which functions to regulate IgE synthesis in general. Whether this defect is acquired or is preexisting is not known. The possibility that the defect is acquired is supported by the low frequency of elevated IgE in patients with inactive coccidioidomycosis. On the other hand, our finding that significant levels of anti-CDN IgE or non-coccidioidal IgE or both can persist long after the disease becomes inactive is more consistent with a preexisting defect, or a predisposition to the defect. Support for the latter is derived from the finding that atopy is genetically linked (26) and that T suppressor cells are encoded by the major histocompatibility complex (4, 40) .
Studies by Buckley and Becker (5), Fiser and Buckley (13) , and Saxon et al. (37, 38) have shown that mononuclear cells of persons with atopic disorders synthesize significant amounts 
